Literature DB >> 8594162

The atom assignment problem in automated de novo drug design. 4. Tests for site-directed fragment placement based on molecular complementarity.

M T Barakat1, P M Dean.   

Abstract

Three previous papers in this series have outlined an optimization method for atom assignment in drug design using fragment placement. In this paper the procedure is rigorously tested on a selection of five ligand-protein co-crystals. The algorithm is presented with the molecular graph of the ligand, and the electrostatic/hydrophobic potential of the site, with the aim of creating a placement on the molecular graph which is as electrostatically complementary or hydrophobically similar to the site as possible. Various designer options were tested, including, where appropriate, hydrogen bonding and a restricted number of halogens. In most cases, the placement obtained was at least as good as the native ligand, if not significantly better.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8594162     DOI: 10.1007/bf00124002

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  10 in total

1.  The refined structure of the complex between adenylate kinase from beef heart mitochondrial matrix and its substrate AMP at 1.85 A resolution.

Authors:  K Diederichs; G E Schulz
Journal:  J Mol Biol       Date:  1991-02-05       Impact factor: 5.469

2.  Structure of a complex of catabolite gene activator protein and cyclic AMP refined at 2.5 A resolution.

Authors:  I T Weber; T A Steitz
Journal:  J Mol Biol       Date:  1987-11-20       Impact factor: 5.469

3.  The atom assignment problem in automated de novo drug design. 5. Tests for envelope-directed fragment placement based on molecular similarity.

Authors:  M T Barakat; P M Dean
Journal:  J Comput Aided Mol Des       Date:  1995-10       Impact factor: 3.686

4.  The atom assignment problem in automated de novo drug design. 1. Transferability of molecular fragment properties.

Authors:  M T Barakat; P M Dean
Journal:  J Comput Aided Mol Des       Date:  1995-08       Impact factor: 3.686

5.  The atom assignment problem in automated de novo drug design. 3. Algorithms for optimization of fragment placement onto 3D molecular graphs.

Authors:  M T Barakat; P M Dean
Journal:  J Comput Aided Mol Des       Date:  1995-08       Impact factor: 3.686

6.  The atom assignment problem in automated de novo drug design. 2. A method for molecular graph and fragment perception.

Authors:  M T Barakat; P M Dean
Journal:  J Comput Aided Mol Des       Date:  1995-08       Impact factor: 3.686

7.  Crystal structures of recombinant human dihydrofolate reductase complexed with folate and 5-deazafolate.

Authors:  J F Davies; T J Delcamp; N J Prendergast; V A Ashford; J H Freisheim; J Kraut
Journal:  Biochemistry       Date:  1990-10-09       Impact factor: 3.162

8.  Crystallographic refinement of human serum retinol binding protein at 2A resolution.

Authors:  S W Cowan; M E Newcomer; T A Jones
Journal:  Proteins       Date:  1990

9.  Crystal structure of p-hydroxybenzoate hydroxylase complexed with its reaction product 3,4-dihydroxybenzoate.

Authors:  H A Schreuder; J M van der Laan; W G Hol; J Drenth
Journal:  J Mol Biol       Date:  1988-02-20       Impact factor: 5.469

Review 10.  Mechanism of pH-induced release of retinol from retinol-binding protein.

Authors:  O B Ptitsyn; G Zanotti; A L Denesyuk; V E Bychkova
Journal:  FEBS Lett       Date:  1993-02-15       Impact factor: 4.124

  10 in total
  2 in total

1.  A branch-and-bound method for optimal atom-type assignment in de novo ligand design.

Authors:  N P Todorov; P M Dean
Journal:  J Comput Aided Mol Des       Date:  1998-07       Impact factor: 3.686

2.  The atom assignment problem in automated de novo drug design. 5. Tests for envelope-directed fragment placement based on molecular similarity.

Authors:  M T Barakat; P M Dean
Journal:  J Comput Aided Mol Des       Date:  1995-10       Impact factor: 3.686

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.